ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea
· Delayed Price · Currency is KRW 983.00
-20.00 (-1.99%)
At close: Mar 31, 2025, 3:30 PM KST
KOSDAQ:034940 Revenue
In the year 2024, ChoA Pharmaceutical Co., LTD. had annual revenue of 62.69B KRW, down -0.44%. ChoA Pharmaceutical Co., LTD. had revenue of 17.01B in the quarter ending December 31, 2024, with 7.82% growth.
Revenue
62.69B
Revenue Growth
-0.44%
P/S Ratio
0.49
Revenue / Employee
250.77M
Employees
250
Market Cap
30.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.69B | -280.00M | -0.44% |
| Dec 31, 2023 | 62.97B | -5.91B | -8.57% |
| Dec 31, 2022 | 68.88B | 11.32B | 19.66% |
| Dec 31, 2021 | 57.56B | -7.80B | -11.93% |
| Dec 31, 2020 | 65.36B | -2.18B | -3.22% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |